Vimab Group AB (publ) (OM:VIMAB) signed letter of intent to acquire Solomon Oy for â¬2.3 million on June 20, 2023. Initial purchase price of â¬1.8 million includes â¬0.5 million in cash, â¬1.3 million in Vimab shares. Signing of share transfer agreement is planned for Q3 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.5 SEK | -1.16% | -9.09% | -4.06% |
08/05 | Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
08/05 | Vimab Group AB (OM:VIMAB) agreed to acquire Tranfoten Aktiebolag. | CI |
1st Jan change | Capi. | |
---|---|---|
-4.06% | 1.79Cr | |
+8.22% | 756.03Cr | |
-32.38% | 305.58Cr | |
+10.72% | 278.16Cr | |
+5.31% | 163.92Cr | |
-19.97% | 95Cr | |
+3.26% | 71Cr | |
-10.88% | 67Cr | |
-4.61% | 60Cr | |
-13.62% | 57Cr |
- Stock Market
- Equities
- VIMAB Stock
- News Vimab Group AB
- Vimab Group AB (OM: VIMAB) signed letter of intent to acquire Solomon Oy for €2.3 million.